本周头条
病理模型少算50倍,保留97%平均性能
本周最强信号不是继续堆参数,而是让模型、验证和生物工程更接近真实工作流。
GigaPath-Flash 把十亿参数教师模型的表征能力蒸馏到 2200 万参数切片编码器和 2100 万参数整张切片编码器。论文报告约 1/50 计算量下保留原模型 97% 的平均整张切片性能;GigaTIME-Flash 还报告 6 倍速度和 8 倍显存节省,并以 Apache 2.0 开放权重。
边界同样重要:97% 是论文所测任务的平均值,不等于临床诊断能力等价;论文仍是 arXiv 预印本,也尚未替代跨医院、跨癌种的独立外部验证。
放到本周十篇原始研究里看,三条趋势很清楚:模型开始认真计算部署成本;临床 AI 更重视分任务和多中心验证;空间组学与生物打印正在把信号推进到机制和组织尺度。
社区脉动 · 已验证公开来源
社交网络雷达
2026-07-26—2026-07-26. 以下条目来自公开 API,并已核验原帖链接与北京时间窗口。它们反映公开关注和讨论,不代表论文质量、临床效力或学术共识。
Keith Bradnam 📈 @kbradnam@hachyderm.io
Bioinformatics and genomics resources on reddit — ACGT
Almost 11 years to the day since I first wrote this blog post, I've gone back and updated it and added new resources. I'm counting this as a new ACGT blog post and have updated the date of it accordingly to appear at the top of my feed: Bioinformatics and genomics resources on r…
Dr. John White @molecular_geneticist
GeneMap Discovery
Raw genomic data can be a maze; GeneMap Discovery transforms it into clear, understandable maps that anyone can navigate. Free for the first week! https:// genemap-discovery.vercel.app # genomics # bioinformatics 🎬 Watch: https://www. youtube.com/watch?v=jUYm222802k
1ban.news @1ban_news
Systematic Review Finds Specialized AI Models Outperform General-Purpose Systems in Bioinformatics Our best stories, delivered daily. Follow us. https:// 1ban.news/arxiv-genai-bioinfor matics-systematic-review-2026/ # 1ban # arxiv # genai # bioinformatics # systematic # tech
RRID Robot @rridrobot.bsky.social
Immune-Responsive Bioinks Enable Vision-Guided in Situ Robotic Bioprinting to Accelerate Diabetic Wound Healing
RRIDs were included in this in Advanced Functional Materials paper. RRIDs improve reproducibility in scientific research. #accelerateopenscience #methodsmatter #reproducibility
Safety In Numbers @safetyinnumbers.bsky.social
Japan Clears First iPSC Therapies for Clinical Use
Just this year, Japan conditionally approved a special iPSC therapy to regrow the heart after major heart attack, and treatment for Parkinson's. themedicinemaker.com/issues/2026/... In contrast, bioprinting organs is still a ways off, alas.